Prognostic value of CD73 expression in resected colorectal cancer liver metastasis-Reference-Cited by-同舟云学术

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Messaoudi Nouredin¹²³⁴,Cousineau Isabelle¹,Arslanian Elizabeth⁵,Henault David¹,Stephen David⁵,Vandenbroucke-Menu Franck²,Dagenais Michel²,Létourneau Richard²,Plasse Marylène²,Roy André²,Lapointe Réal²,Ysebaert Dirk³,Trudel Dominique¹⁵,Soucy Geneviève⁵,Stagg John¹,Turcotte Simon¹²

Affiliation:

1. Cancer Axis, Centre de Recherche Du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada

2. Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada

3. Department of Surgery, University of Antwerp, Antwerp, Belgium

4. Department of Surgery, University Hospital of Brussels (UZ Brussel) and Europe Hospitals, Brussels, Belgium

5. Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada

Funder

Surface Oncology

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1746138

Reference33 articles.

1. Cancer statistics, 2019

2. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

3. Evolution of Metastases in Space and Time under Immune Selection

4. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival

5. Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications;Biomarker Research;2024-09-02

2. High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells;Biomedicine & Pharmacotherapy;2024-08

3. COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer;British Journal of Cancer;2024-07-25

4. Establishment and validation of diagnostic and prognostic prediction models for liver metastasis in patients with rectal cancer: a SEER based study.;2024-04-30

5. Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients;Archivos de Bronconeumología;2024-04